Literature DB >> 17456619

Potential thrombogenic complications with the use of recombinant activated factor VII in combat trauma.

Jawed Fareed, Rodger L Bick, Craig Kessler, Harry L Messmore, Gundu Rao, Arthur Sasahara, Sylvia Haas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17456619     DOI： 10.1177/1076029606298733

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


× No keyword cloud information.
  1 in total

1.  Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients.

Authors:  Bartolomeu Nascimento; Yulia Lin; Jeannie Callum; Marciano Reis; Ruxandra Pinto; Sandro Rizoli
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.